Archive: 12/03/2010

Assessing positive outcomes of phase III trials

Randomized phase III studies should be designed to find out whether a new drug or treatment makes a meaningful difference in patients' survival or quality of life, according to a commentary published online December 3rd in ...

dateDec 03, 2010 in Cancer
shares0 comments 0

Using nanotechnology to improve cancer treatment

(PhysOrg.com) -- Research directed by Basar Bilgicer, assistant professor of chemical and biomolecular engineering and a member of the Advanced Diagnostics and Therapeutics initiative at the University of Notre Dame, could ...

dateDec 03, 2010 in Bio & Medicine
shares0 comments 1

WikiLeaks fights to stay online amid attacks

(AP) -- WikiLeaks struggled to stay online Friday as corporations and governments moved to cut its access to the Internet, a potentially crippling blow for an organization dedicated to releasing secret information ...

dateDec 03, 2010 in Internet
shares0 comments 5

Scientists untangle spider web stickiness

Ali Dhinojwala and Vasav Sahni consider themselves materials scientists, not biologists. They study surfaces, friction and adhesion. Nevertheless, they have discovered that understanding how nature makes things ...

dateDec 03, 2010 in Materials Science
shares0 comments 0